Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Sanofi ( (SNY)) has issued an announcement. On January 12, 2026, the European Commission approved Sanofi’s Teizeild (teplizumab) as the first disease‑modifying therapy in the European Union to delay ...

Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and potential side effects.

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...

For the first time, a state board was able to tell lawmakers Thursday it is taking steps to bring prescription drug costs ...

Division bench of Delhi HC overturned 2019 order by single-judge bench, restoring ban on manufacture, sale, and distribution of triple-drug combinations for type 2 diabetes.

Low-income Californians who use Zepbound and similar medications for weight loss lost their coverage at the start of the new ...

ACC scientific statement highlights the high prevalence of unrecognized PAD in patients with diabetes and provides a framework for screening and care.

A GP has claimed there are three types of medication that he doesn't like prescribing to his patients, as there's usually a ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

The World Health Organisation will this year start to work with scientists and drug developers to gather more information ...